Stock comparison
IDEXX Laboratories
Tactile Systems Technology
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IDXX
IDEXX Laboratories
Market cap
$44.12B
Sector
Healthcare
TCMD
Tactile Systems Technology
Market cap
$561.65M
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IDXX | TCMD | Winner |
|---|---|---|---|
| Warren Buffett | 75B | 54D | IDXX |
| Benjamin Graham | 80A | 55D | IDXX |
| Philip Fisher | 75B | 48D | IDXX |
| Peter Lynch | 71B | 38D | IDXX |
| Joel Greenblatt | 83C | 30F | IDXX |
| Charlie Munger | 87A | 41D | IDXX |
| Terry Smith | 84A | 47D | IDXX |
Side-by-side metrics
| Metric | IDXX | TCMD |
|---|---|---|
| Market cap | $44.12B | $561.65M |
| P/E (TTM) | 39.0x | 26.6x |
| EV/EBIT | 31.6x | 16.4x |
| ROIC (TTM) | 40.66% | 7.93% |
| Gross margin | 62.05% | 75.68% |
| Net margin | 24.63% | 5.91% |
| Revenue CAGR 5y | 7.56% | 12.18% |
| EPS CAGR 5y | 10.79% | - |
| Debt / Equity | 0.7x | 0.1x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IDXX leads on
- Market cap$44.12Bvs $561.65M+99%
- ROIC (TTM)40.66%vs 7.93%+80%
- Net margin24.63%vs 5.91%+76%
TCMD leads on
- Debt / Equity0.1xvs 0.7x+90%
- EV/EBIT16.4xvs 31.6x+48%
- Revenue CAGR 5y12.18%vs 7.56%+38%
- P/E (TTM)26.6xvs 39.0x+32%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.